Press Releases | Medtronic

Month Year

Email alerts

Feb 19, 2016

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2016

DUBLIN - February 19, 2016 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2016 fourth quarter cash dividend of $0.38 per ordinary share, representing a 25...
Feb 19, 2016

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016

DUBLIN - February 19, 2016 - Medtronic plc (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2016 on Tuesday, March 1, 2016. A news release will...
Feb 18, 2016

Meta-Analysis Shows Medtronic's Solitaire(TM) Stent Retriever Device Improves Functional Outcomes for Acute Ischemic Stroke Patients; Reduced Mortality in Patients 80+

SEER Pooled, Patient-Level Analysis of SWIFT PRIME, EXTEND-IA, ESCAPE and REVASCAT Shows Safety and Efficacy of Solitaire Device

DUBLIN - February 18, 2016 - A meta-analysis published online today in Stroke and presented at the International Stroke Conference (ISC) in Los Angeles, Calif., found that the addition of...
Feb 17, 2016

FDA Approves Medtronic Deep Brain Stimulation for People with Parkinson's Disease with Recent Onset of Motor Complications

Approval Expands Population of Individuals Who May Benefit From the Proven Therapy

DUBLIN - February 17, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Medtronic Deep Brain Stimulation (DBS) Therapy for use in people with...
Feb 12, 2016

NICE Recommends Medtronic Integrated Sensor-Augmented Insulin Pump As the Only Therapy System to Manage Glucose Levels in Type 1 Diabetes

The NICE guidance reviewed two sensor-augmented insulin pump therapy systems and recommends the MiniMed® Paradigm Veo(TM) system for managing glucose levels in people with Type 1 diabetes.1

DUBLIN - February 12, 2016 - Today, the United Kingdom's National Institute for Health and Care Excellence (NICE) has issued positive guidance for the use of Medtronic insulin pump systems...
Feb 12, 2016

HeartWare Schedules Fourth Quarter 2015 Financial Results Conference Call And Webcast

HeartWare International, Inc. (NASDAQ: HTWR) has scheduled a conference call and webcast to discuss its financial results for the three and 12 months ended December 31, 2015, on Thursday, February...
Feb 9, 2016

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

Sanford Health in Collaboration with Medtronic Leads Global Efforts to Address Challenging Vascular Condition

DUBLIN and SIOUX FALLS, S.D. - February 9, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation's largest health...
Feb 5, 2016

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

Amplia MRI(TM) and Compia MRI(TM) CRT-Ds, Approved for Patients with Heart Failure, Can Safely Undergo Full Body MRI Scans

DUBLIN - Feb. 5, 2016 - Medtronic plc (NYSE:MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the first and only magnetic resonance imaging (MRI)...
Feb 5, 2016

Medtronic's iPro(TM)2 Professional CGM Shows Benefits for People with Type 2 Diabetes

iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy

MILAN - February 5, 2016 - A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, demonstrates that patients with type 2...
Feb 2, 2016

HeartWare Presentation At The Leerink Partners 5th Annual Global Healthcare Conference To Be Webcast

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

Show per page